Cargando…

The Application of the GP Model to Manage Controllable Risk Factors in Stroke Patients with Diabetes Can Effectively Improve the Prognosis and Reduce the Recurrence Rate

OBJECTIVE: The aim of this study is to examine the impacts of general practice model (GP) on prognosis and recurrence of stroke patients with diabetes. METHODS: Ninety patients with stroke combined with diabetes mellitus admitted to our hospital from June 2019 to June 2020 were selected for the stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Zhehua, Liu, Kai, Li, Yunjing, Yi, Shuangyan, Wang, Xiaotang, Yu, Changying, Zhu, Haiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374552/
https://www.ncbi.nlm.nih.gov/pubmed/35966752
http://dx.doi.org/10.1155/2022/5413985
Descripción
Sumario:OBJECTIVE: The aim of this study is to examine the impacts of general practice model (GP) on prognosis and recurrence of stroke patients with diabetes. METHODS: Ninety patients with stroke combined with diabetes mellitus admitted to our hospital from June 2019 to June 2020 were selected for the study and were randomly and equally divided into 45 cases each in the control and experimental groups for the prospective trial. The patients in the control group received routine treatment while those in the experimental group were treated with GP model. Comparison in treatment effects, patients satisfaction, psychological status, quality of life, glycosylated hemoglobin level, and stroke recurrence was carried out between the two groups. RESULTS: The experimental group showed markedly better treatment effects (P < 0.05), higher satisfaction degree (P < 0.05), higher HAD (P < 0.05), GQOLI-74 score (P < 0.05), and BI index (P < 0.05), lower level of glycosylated hemoglobin (P < 0.05), and much lower recurrence rate (P < 0.05), as compared to the control group. CONCLUSION: The application of the GP model to manage controllable risk factors in stroke patients with diabetes can effectively improve the prognosis and reduce the recurrence rate, which is worthy of clinical application and promotion.